TOKYO -- Japan's health ministry on Thursday approved Pfizer's COVID-19 pill Paxlovid for patients with mild to moderate symptoms, making it the second such oral medication to receive the fast-track treatment.
The government has already set aside doses of Paxlovid for 40,000 people, and delivery of the pills to health care facilities will start on Monday.
re.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
